by John McMillan | Aug 16, 2024 | COVID-19, Medical Research
Ziyad Al-Aly, Washington University in St. Louis Since 2020, the condition known as long COVID-19 has become a widespread disability affecting the health and quality of life of millions of people across the globe and costing economies billions of dollars in reduced...
by John McMillan | Aug 16, 2024 | Health, Medical Research
Tatiane Vilaca, University of Sheffield and Richard Eastell, University of Sheffield A new anti-osteoporosis drug has just been approved for use in the UK. The drug, called abaloparatide, is licensed for post-menopausal women with osteoporosis and a very high risk of...
by John McMillan | Aug 16, 2024 | Health, Virology
C Raina MacIntyre, UNSW Sydney The World Health Organization (WHO) has declared mpox a public health emergency of international concern, after rising cases in the Democratic Republic of the Congo and the potential for further spread. This now triggers a coordinated...
by John McMillan | Aug 16, 2024 | COVID-19, Heart Failure
Dr. Philip McMillan, John McMillan On a routine visit to her local clinic, 78-year-old Mrs. Nakamura received a third COVID-19 vaccine dose (mRNA-1273) after previously receiving two doses of BNT162b2. Four days later, she began experiencing palpitations and...
by John McMillan | Aug 9, 2024 | Dental, Health
Amal Elamin, University of Greenwich Oral diseases, such as tooth decay and gum disease, are among the the most widespread chronic illnesses globally – affecting an estimated 3.5 billion people. They pose a significant problem not just because of how common they are,...
Recent Comments